SpringWorks Therapeutics, Inc. (SWTX) Analyst Estimates Annual - Discounting Cash Flows
SWTX
SpringWorks Therapeutics, Inc.
SWTX (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2021
12-31
2020
12-31
Number of Analysts 1 1 2 3 4 6 5 11 5
Estimated Revenue
Low 818.3 701.2 658.5 480.5 297.6 169.4 67.63 0 17.52
Average 1,043 893.6 839.2 612.3 335.1 190.9 86.19 0 21
High 1,291 1,106 1,039 758.2 402.9 201.1 106.7 0 23.86
Estimated EBITDA
Low -774.8 -663.9 -623.5 -454.9 -241.7 -120.7 -64.03 -153.3 -19.44
Average -625.7 -536.2 -503.5 -367.4 -201 -114.5 -51.71 -127.7 0.87
High -491 -420.7 -395.1 -288.3 -178.6 -101.6 -40.58 -102.2 21.18
Estimated EBIT
Low -774.8 -663.9 -623.5 -454.9 -241.7 -120.7 -64.03 -153.7 -20.29
Average -625.7 -536.2 -503.5 -367.4 -201 -114.5 -51.71 -128.1 -0.076
High -491 -420.7 -395.1 -288.3 -178.6 -101.6 -40.58 -102.5 20.13
Estimated Net Income
Low 83.81 208.2 -60.77 -146.2 -323.8 -234 -424.1 -154.1 -19.2
Average 116.4 289.1 76.3 -86.16 -287.3 -223.1 -301.1 -128.4 0.908
High 152.4 378.7 316.3 16.54 -63.39 -212.2 -233.2 -102.7 21.02
Estimated SGA Expenses
Low 10,039 8,602 8,078 5,894 3,651 2,078 829.6 0.002 213.8
Average 12,794 10,962 10,295 7,512 4,110 2,341 1,057 0.002 256.2
High 15,842 13,574 12,747 9,301 4,942 2,467 1,309 0.003 291.1
Estimated EPS
Low 1.13 2.81 -0.82 -1.97 -4.37 -3.16 -5.72 -3.67 -1.61
Average 1.57 3.9 1.72 -0.825 -2.75 -3.05 -4.37 -3.11 -1.37
High 2.06 5.11 4.27 0.223 -0.855 -2.86 -3.15 -2.44 -1.07
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program